Drreddys Laboratories reported INR269.9B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
ANI Pharmaceuticals USD 602.63M 66.34M Jun/2025
Aurora Cannabis CAD 465.3M 28.91M Jun/2025
Bayer EUR 33.75B 1.08B Jun/2025
Canopy Growth CAD 303.36M 37.72M Jun/2025
Cipla INR 232.89B 23.43B Mar/2025
Corcept Therapeutics USD 443.11M 4.61M Jun/2025
Drreddys Laboratories INR 269.9B 16.88B Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
Hikma Pharmaceutical USD 2.26B 22M Dec/2024
Lonza CHF 5.44B 113M Dec/2024
Novartis USD 25.94B 831M Jun/2025
Pacira USD 745.61M 14.35M Jun/2025
Prestige Brands USD 480.52M 32.19M Jun/2025
Richter Gedeon HUF 641.06B 69.19B Dec/2024
Sun Pharmaceuticals INR 525.94B 64.89B Mar/2025
Supernus Pharmaceuticals USD 738.87M 51.28M Jun/2025
Teva Pharmaceutical Industries USD 12.62B 1.09B Jun/2025